An isolated cryptic peptide influences osteogenesis and bone remodeling in an adult mammalian model of digit amputation

Tissue Engineering - Part A

Volumn 17, Issue 23-24, 2011, Pages 3033-3044

  Agrawal, Vineet ^a   Kelly, Jeremy ^a,b   Tottey, Stephen ^a,b   Daly, Kerry A ^a,b   Johnson, Scott A ^a,b   Siu, Bernard F ^a,c   Reing, Janet ^a,b   Badylak, Stephen F ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c University of Pittsburgh   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; ENZYME ACTIVITY; GENE EXPRESSION; MAMMALS; PEPTIDES; PHOSPHATASES; STEM CELLS; TISSUE;

ALKALINE PHOSPHATASE ACTIVITY; BONE INJURY; BONE NODULES; BONE REMODELING; CALCIUM DEPOSITION; CHEMOTACTIC ACTIVITY; EXTRACELLULAR MATRICES; IN-VITRO; MICROENVIRONMENTS; MURINE MODEL; OSTEOGENESIS; OSTEOGENIC; OSTEOGENIC ACTIVITY; PROGENITOR CELL; SCAFFOLD DEGRADATION; SURGICAL PROCEDURES;

SCAFFOLDS (BIOLOGY);

MAMMALIA; MURINAE;

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; PEPTIDE; TRANSCRIPTION FACTOR SOX;

ADIPOGENESIS; AGING; AMINO ACID SEQUENCE; AMPUTATION; ANIMAL; ANIMAL MODEL; ARTICLE; BONE DEVELOPMENT; BONE REMODELING; C57BL MOUSE; CELL PROLIFERATION; CHEMISTRY; CHONDROGENESIS; CYTOLOGY; DRUG EFFECT; ENZYMOLOGY; FORELIMB; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MAMMAL; METABOLISM; MOLECULAR GENETICS; MOUSE; STEM CELL; TOE;

ADIPOGENESIS; AGING; ALKALINE PHOSPHATASE; AMINO ACID SEQUENCE; AMPUTATION; ANIMALS; BIOLOGICAL MARKERS; BONE REMODELING; CELL PROLIFERATION; CHONDROGENESIS; FORELIMB; HUMANS; MAMMALS; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; MOLECULAR SEQUENCE DATA; OSTEOGENESIS; PEPTIDES; SOXB1 TRANSCRIPTION FACTORS; STEM CELLS; TOES;

EID: 82355164089     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2011.0257     Document Type: Article

References (76)

1. Caione, P., Capozza, N., Zavaglia, D., Palombaro, G., and Boldrini, R. In vivo bladder regeneration using small intestinal submucosa: experimental study. Pediatr Surg Int 22, 593, 2006.
2. Cobb, M.A., Badylak, S.F., Janas, W., and Boop, F.A. Histology after dural grafting with small intestinal submucosa. Surg Neurol 46, 389; discussion 93-94, 1996.
3. Lantz, G.C., Badylak, S.F., Coffey, A.C., Geddes, L.A., and Blevins, W.E. Small intestinal submucosa as a small-diameter arterial graft in the dog. J Invest Surg 3, 217, 1990.
4. Hodde, J.P., Badylak, S.F., and Shelbourne, K.D. The effect of range of motion on remodeling of small intestinal submucosa (SIS) when used as an achilles tendon repair material in the rabbit. Tissue Eng 3, 27, 1997.
5. Uygun, B.E., Soto-Gutierrez, A., Yagi, H., Izamis, M.L., Guzzardi, M.A., Shulman, C., et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix. Nat Med 16, 814, 2010.
6. Ott, H.C., Clippinger, B., Conrad, C., Schuetz, C., Pomerantseva, I., Ikonomou, L., et al. Regeneration and orthotopic transplantation of a bioartificial lung. Nat Med 16, 927, 2010.
7. Ott, H.C., Matthiesen, T.S., Goh, S.K., Black, L.D., Kren, S.M., Netoff, T.I., et al. Perfusion-decellularized matrix: using nature's platform to engineer a bioartificial heart. Nat Med 14, 213, 2008.
8. Badylak, S., Meurling, S., Chen, M., Spievack, A., and Simmons-Byrd, A. Resorbable bioscaffold for esophageal repair in a dog model. J Pediatr Surg 35, 1097, 2000.
9. Badylak, S.F., Lantz, G.C., Coffey, A., and Geddes, L.A. Small intestinal submucosa as a large diameter vascular graft in the dog. J Surg Res 47, 74, 1989.
10. Zalavras, C.G., Gardocki, R., Huang, E., Stevanovic, M., Hedman, T., and Tibone, J. Reconstruction of large rotator cuff tendon defects with porcine small intestinal submucosa in an animal model. J Shoulder Elbow Surg 15, 224, 2006.
11. Metcalf, M.H., Savoie, F.H., and Kellum, B. Surgical technique for xenograft (SIS) augmentation of rotator-cuff repairs. Oper Tech Orthop 12, 204, 2002.
12. Derwin, K.A., Badylak, S.F., Steinmann, S.P., and Iannotti, J.P. Extracellular matrix scaffold devices for rotator cuff repair. J Shoulder Elbow Surg 19, 467, 2010.
13. Mase, V.J., Jr., Hsu, J.R., Wolf, S.E., Wenke, J.C., Baer, D.G., Owens, J., et al. Clinical application of an acellular biologic scaffold for surgical repair of a large, traumatic quadriceps femoris muscle defect. Orthopedics 33, 511, 2010.
14. Witteman, B.P., Foxwell, T.J., Monsheimer, S., Gelrud, A., Eid, G.M., Nieponice, A., et al. Transoral endoscopic inner layer esophagectomy: management of high-grade dysplasia and superficial cancer with organ preservation. J Gastrointest Surg 13, 2104, 2009.
15. Valentin, J.E., Stewart-Akers, A.M., Gilbert, T.W., and Badylak, S.F. Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds. Tissue Eng Part A 15, 1687, 2009.
16. Zantop, T., Gilbert, T.W., Yoder, M.C., and Badylak, S.F. Extracellular matrix scaffolds are repopulated by bone marrow-derived cells in a mouse model of achilles tendon reconstruction. J Orthop Res 24, 1299, 2006.
17. Badylak, S.F., Park, K., Peppas, N., McCabe, G., and Yoder, M. Marrow-derived cells populate scaffolds composed of xenogeneic extracellular matrix. Exp Hematol 29, 1310, 2001.
18. Agrawal, V., Johnson, S.A., Reing, J., Zhang, L., Tottey, S., Wang, G., et al. Epimorphic regeneration approach to tissue replacement in adult mammals. Proc Natl Acad Sci USA 107, 3351, 2010.
19. Badylak, S.F., Valentin, J.E., Ravindra, A.K., McCabe, G.P., and Stewart-Akers, A.M. Macrophage phenotype as a determinant of biologic scaffold remodeling. Tissue Eng Part A 14, 1835, 2008.
20. Valentin, J.E., Badylak, J.S., McCabe, G.P., and Badylak, S.F. Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study. J Bone Joint Surg Am 88, 2673, 2006.
21. Gilbert, T.W., Stewart-Akers, A.M., and Badylak, S.F. A quantitative method for evaluating the degradation of biologic scaffold materials. Biomaterials 28, 147, 2007.
22. Record, R.D., Hillegonds, D., Simmons, C., Tullius, R., Rickey, F.A., Elmore, D., et al. In vivo degradation of 14Clabeled small intestinal submucosa (SIS) when used for urinary bladder repair. Biomaterials 22, 2653, 2001.
23. Davis, G.E. Matricryptic sites control tissue injury responses in the cardiovascular system: relationships to pattern recognition receptor regulated events. J Mol Cell Cardiol 48, 454, 2010.
24. Davis, G.E., Bayless, K.J., Davis, M.J., and Meininger, G.A. Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules. Am J Pathol 156, 1489, 2000.
25. Ganz, T. Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3, 710, 2003.
26. Moore, A.J., Beazley, W.D., Bibby, M.C., and Devine, D.A. Antimicrobial activity of cecropins. J Antimicrob Chemother 37, 1077, 1996.
27. Moore, A.J., Devine, D.A., and Bibby, M.C. Preliminary experimental anticancer activity of cecropins. Pept Res 7, 265, 1994.
28. Berkowitz, B.A., Bevins, C.L., and Zasloff, M.A. Magainins: a new family of membrane-active host defense peptides. Biochem Pharmacol 39, 625, 1990.
29. Li, F., Li, W., Johnson, S., Ingram, D., Yoder, M., and Badylak, S. Low-molecular-weight peptides derived from extracellular matrix as chemoattractants for primary endothelial cells. Endothelium 11, 199, 2004.
30. Adair-Kirk, T.L., and Senior, R.M. Fragments of extracellular matrix as mediators of inflammation. Int J Biochem Cell Biol 40, 1101, 2008.
31. Agrawal, V., Brown, B.N., Beattie, A.J., Gilbert, T.W., and Badylak, S.F. Evidence of innervation following extracellular matrix scaffold-mediated remodelling of muscular tissues. J Tissue Eng Regen Med 3, 590, 2009.
32. Brennan, E.P., Tang, X.H., Stewart-Akers, A.M., Gudas, L.J., and Badylak, S.F. Chemoattractant activity of degradation products of fetal and adult skin extracellular matrix for keratinocyte progenitor cells. J Tissue Eng RegenMed 2, 491, 2008.
33. Crisan, M., Yap, S., Casteilla, L., Chen, C.W., Corselli, M., Park, T.S., et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell 3, 301, 2008.
34. Reing, J.E., Zhang, L., Myers-Irvin, J., Cordero, K.E., Freytes, D.O., Heber-Katz, E., et al. Degradation products of extracellular matrix affect cell migration and proliferation. Tissue Eng Part A 15, 605, 2009.
35. Tottey, S., Corselli, M., Jeffries, E.M., Londono, R., Peault, B., and Badylak, S.F. Extracellular matrix degradation products and low-oxygen conditions enhance the regenerative potential of perivascular stem cells. Tissue Eng Part A 17, 37, 2011.
36. Agrawal, V., Tottey, S., Johnson, S.A., Freund, J., Siu, B.F., and Badylak, S.F. Recruitment of progenitor cells by an ECM cryptic peptide in a mouse model of digit amputation. Tissue Eng Part A 2011 [Epub ahead of print]; DOI:10.1089/ten.tea.2011.0036.
37. Alford, A.I., and Hankenson, K.D. Matricellular proteins: extracellular modulators of bone development, remodeling, and regeneration. Bone 38, 749, 2006.
38. Schotte, O.E., and Smith, C.B. Wound healing processes in amputated mouse digits. Biol Bull 117, 546, 1959.
39. Schotte, O.E., and Smith, C.B. Effects of ACTH and of cortisone upon amputational wound healing processes in mice digits. J Exp Zool 146, 209, 1961.
40. Tottey, S., Corselli, M., Jeffries, E.M., Londono, R., Peault, B., and Badylak, S.F. Extracellular matrix degradation products and low-oxygen conditions enhance the regenerative potential of perivascular stem cells. Tissue Eng Part A 17, 37, 2011.
41. Gregory, C.A., Gunn, W.G., Peister, A., and Prockop, D.J. An Alizarin red-based assay of mineralization by adherent cells in culture: comparison with cetylpyridinium chloride extraction. Anal Biochem 329, 77, 2004.
42. Trouba, K.J., Wauson, E.M., and Vorce, R.L. Sodium arsenite inhibits terminal differentiation of murine C3H 10T1/2 preadipocytes. Toxicol Appl Pharmacol 168, 25, 2000.
43. Parfitt, A.M., Drezner, M.K., Glorieux, F.H., Kanis, J.A., Malluche, H., Meunier, P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2, 595, 1987.
44. Holstein, J.H., Klein, M., Garcia, P., Histing, T., Culemann, U., Pizanis, A., et al. Rapamycin affects early fracture healing in mice. Br J Pharmacol 154, 1055, 2008.
45. Neufeld, D.A., and Zhao, W. Bone regrowth after digit tip amputation in mice is equivalent in adults and neonates. Wound Repair Regen 3, 461, 1995.
46. Zhao, W., and Neufeld, D.A. Bone regrowth in young mice stimulated by nail organ. J Exp Zool 271, 155, 1995.
47. Basu-Roy, U., Ambrosetti, D., Favaro, R., Nicolis, S.K., Mansukhani, A., and Basilico, C. The transcription factor Sox2 is required for osteoblast self-renewal. Cell Death Differ 17, 1345, 2010.
48. Mansukhani, A., Ambrosetti, D., Holmes, G., Cornivelli, L., and Basilico, C. Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation. J Cell Biol 168, 1065, 2005.
49. Autelitano, D.J., Rajic, A., Smith, A.I., Berndt, M.C., Ilag, L.L., and Vadas, M. The cryptome: a subset of the proteome, comprising cryptic peptides with distinct bioactivities. Drug Discov Today 11, 306, 2006.
50. Mukai, H., Seki, T., Nakano, H., Hokari, Y., Takao, T., Kawanami, M., et al. Mitocryptide-2: purification, identification, and characterization of a novel cryptide that activates neutrophils. J Immunol 182, 5072, 2009.
51. Mukai, H., Hokari, Y., Seki, T., Takao, T., Kubota, M., Matsuo, Y., et al. Discovery of mitocryptide-1, a neutrophilactivating cryptide from healthy porcine heart. J Biol Chem 283, 30596, 2008.
52. Ng, J.H., and Ilag, L.L. Cryptic protein fragments as an emerging source of peptide drugs. IDrugs 9, 343, 2006.
53. Pimenta, D.C., and Lebrun, I. Cryptides: buried secrets in proteins. Peptides 28, 2403, 2007.
54. Kitahara, T., Takeishi, Y., Arimoto, T., Niizeki, T., Koyama, Y., Sasaki, T., et al. Serum carboxy-terminal telopeptide of type I collagen (ICTP) predicts cardiac events in chronic heart failure patients with preserved left ventricular systolic function. Circ J 71, 929, 2007.
55. Banfi, G., Lombardi, G., Colombini, A., and Lippi, G. Bone metabolism markers in sports medicine. Sports Med 40, 697, 2010.
56. Kanoupakis, E.M., Manios, E.G., Kallergis, E.M., Mavrakis, H.E., Goudis, C.A., Saloustros, I.G., et al. Serum markers of collagen turnover predict future shocks in implantable cardioverter-defibrillator recipients with dilated cardiomyopathy on optimal treatment. J Am Coll Cardiol 55, 2753, 2010.
57. Lee, S.T., Yun, J.I., Jo, Y.S., Mochizuki, M., van der Vlies, A.J., Kontos, S., et al. Engineering integrin signaling for promoting embryonic stem cell self-renewal in a precisely defined niche. Biomaterials 31, 1219, 2011.
58. Dickinson, B.P., Ashley, R.K., Wasson, K.L., O'Hara, C., Gabbay, J., Heller, J.B., et al. Reduced morbidity and improved healing with bone morphogenic protein-2 in older patients with alveolar cleft defects. Plast Reconstr Surg 121, 209, 2008.
59. Rogozinski, A., Rogozinski, C., and Cloud, G. Accelerating autograft maturation in instrumented posterolateral lumbar spinal fusions without donor site morbidity. Orthopedics 32, 809, 2009.
60. Mannion, R.J., Nowitzke, A.M., and Wood, M.J. Promoting fusion in minimally invasive lumbar interbody stabilization with low-dose bone morphogenic protein-2-but what is the cost? Spine J 11, 527, 2011.
61. Ai-Aql, Z.S., Alagl, A.S., Graves, D.T., Gerstenfeld, L.C., and Einhorn, T.A. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 87, 107, 2008.
62. De Bari, C., Dell'Accio, F., Vanlauwe, J., Eyckmans, J., Khan, I.M., Archer, C.W., et al. Mesenchymal multipotency of adult human periosteal cells demonstrated by single-cell lineage analysis. Arthritis Rheum 54, 1209, 2006.
63. Zhang, X., Xie, C., Lin, A.S., Ito, H., Awad, H., Lieberman, J.R., et al. Periosteal progenitor cell fate in segmental cortical bone graft transplantations: implications for functional tissue engineering. J Bone Miner Res 20, 2124, 2005.
64. Lutton, C., and Goss, B. Caring about microenvironments. Nat Biotechnol 26, 613, 2008.
65. Watt, F.M., and Hogan, B.L. Out of Eden: stem cells and their niches. Science 287, 1427, 2000.
66. Chow, A., Lucas, D., Hidalgo, A., Mendez-Ferrer, S., Hashimoto, D., Scheiermann, C., et al. Bone marrow CD169 + macrophages promote the retention of hematopoietic stem and progenitor cells in the mesenchymal stem cell niche. J Exp Med 208, 261, 2011.
67. Keung, A.J., Kumar, S., and Schaffer, D.V. Presentation counts: microenvironmental regulation of stem cells by biophysical and material cues. Annu Rev Cell Dev Biol 26, 533, 2010.
68. Discher, D.E., Mooney, D.J., and Zandstra, P.W. Growth factors, matrices, and forces combine and control stem cells. Science 324, 1673, 2009.
69. Kienstra, K.A., Jackson, K.A., and Hirschi, K.K. Injury mechanism dictates contribution of bone marrow-derived cells to murine hepatic vascular regeneration. Pediatr Res 63, 131, 2008.
70. Majka, S.M., Jackson, K.A., Kienstra, K.A., Majesky, M.W., Goodell, M.A., and Hirschi, K.K. Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest 111, 71, 2003.
71. Jackson, K.A., Majka, S.M., Wang, H., Pocius, J., Hartley, C.J., Majesky, M.W., et al. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest 107, 1395, 2001.
72. Xia, M., and Zhu, Y. Fibronectin fragment activation of ERK increasing integrin alpha(5) and beta(1) subunit expression to degenerate nucleus pulposus cells. J Orthop Res 29, 556, 2011.
73. Horton, M.A., Spragg, J.H., Bodary, S.C., and Helfrich, M.H. Recognition of cryptic sites in human and mouse laminins by rat osteoclasts is mediated by beta 3 and beta 1 integrins. Bone 15, 639, 1994.
74. Agrez, M.V., Bates, R.C., Boyd, A.W., and Burns, G.F. Arg-Gly-Asp-containing peptides expose novel collagen receptors on fibroblasts: implications for wound healing. Cell Regul 2, 1035, 1991.
75. Shih, Y.R., Tseng, K.F., Lai, H.Y., Lin, C.H., and Lee, O.K. Matrix stiffness regulation of integrin-mediated mechanotransduction during osteogenic differentiation of human mesenchymal stem cells. J Bone Miner Res 26, 730, 2011.
76. Chavakis, E., Aicher, A., Heeschen, C., Sasaki, K., Kaiser, R., El Makhfi, N., et al. Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med 201, 63, 2005.